Literature DB >> 15837537

Different anticancer effects of fluvastatin on primary hepatocellular tumors and metastases in rats.

György Paragh1, Gabriella Fóris, György Paragh1, Ildikó Seres, Zsolt Karányi, Péter Fülöp, Zoltán Balogh, Béla Kosztáczky, Farkas Teichmann, Pál Kertai.   

Abstract

Rats (FLF1) were pretreated with 2 and 20 mg/kg/day fluvastatin (Flu), and after 6 weeks, hepatocellular tumor cells were inoculated under the left renal capsule. At different times, growth and pyruvate kinase (PK) activity of the primary tumors and lymph node metastases were determined. Flu had a dose-dependent inhibitory effect on primary and metastatic tumors, and the inhibitory effect on growth and PK activity in metastases were higher than in primary tumors. Finally, Flu had an earlier inhibitory effect on the early appeared PK activity in metastases than in primary tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837537     DOI: 10.1016/j.canlet.2004.09.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Statins are associated with reduced risk of gastric cancer: a meta-analysis.

Authors:  Xiao-Dan Wu; Kai Zeng; Fang-Qin Xue; Jin-Hua Chen; Yan-Qing Chen
Journal:  Eur J Clin Pharmacol       Date:  2013-06-09       Impact factor: 2.953

2.  Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain.

Authors:  Richard J Calvert; Shirley Tepper; Wafa Kammouni; Lucy M Anderson; David Kritchevsky
Journal:  Biochem Pharmacol       Date:  2006-09-03       Impact factor: 5.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.